18 related articles for article (PubMed ID: 10806144)
1. Acute Lung Functional and Airway Remodeling Effects of an Inhaled Highly Selective Phosphodiesterase 4 Inhibitor in Ventilated Preterm Lambs Exposed to Chorioamnionitis.
Hütten MC; Brokken T; Widowski H; Monaco T; Schneider JP; Fehrholz M; Ophelders D; Kramer BW; Kunzmann S
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678525
[TBL] [Abstract][Full Text] [Related]
2. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?
Suresh GK; Soll RF
Paediatr Drugs; 2002; 4(8):485-92. PubMed ID: 12126452
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
Häfner D; Ibrahim M; Wollin L; Germann PG
Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
[TBL] [Abstract][Full Text] [Related]
4. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury.
Häfner D; Germann PG; Hauschke D; Kilian U
Pulm Pharmacol Ther; 1999; 12(3):193-201. PubMed ID: 10419839
[TBL] [Abstract][Full Text] [Related]
5. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
[TBL] [Abstract][Full Text] [Related]
6. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
Häfner D; Germann PG; Hauschke D
Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone enhances the activity of rSP-C surfactant but not of exosurf in a rat model of the acute lung injury.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999 Sep; 42(1):39-48. PubMed ID: 10715602
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of phosphodiesterase-4 inhibition on effects of rSP-C surfactant.
Häfner D; Germann PG
Am J Respir Crit Care Med; 2000 May; 161(5):1495-500. PubMed ID: 10806144
[TBL] [Abstract][Full Text] [Related]
9. Exogenous surfactant as a drug delivery agent.
Haitsma JJ; Lachmann U; Lachmann B
Adv Drug Deliv Rev; 2001 Apr; 47(2-3):197-207. PubMed ID: 11311992
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
